Business
PathAI: Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs SECAUCUS, N.J. and BOSTON –...
CHICAGO--(BUSINESS WIRE)--Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration...
The Extension Funds Nucleai to Advance Its First-in-Class Spatial AI Biomarker in Active Clinical Enrollment Investment Expands Deployments of AI-Powered Spatial Biomarker Technology, Strengthening Companion Diagnostics for ADCs,...
QDx and Proscia: Empowering pathologists and advancing its practice with innovation EDISON, N.J. and PHILADELPHIA – March 19, 2024 – QDx Pathology Services, an independent anatomical, molecular, and clinical pathology laboratory serving...
From Royal Philips: Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaboration Collaboration combines best of clinical workflow leadership with scalable cloud...
Owkin selects Amazon Web Services (AWS) as its primary cloud provider to develop generative AI applications and accelerate drug discovery and development The company will leverage AWS’s scalable storage options, enhanced data security...
